Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.39 |
| ▸ | ACLY | P53396 | 6/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17048114 | 0.82 | EPAS1 (0.37) | CA1CA2 | |
| SCHEMBL29607374 | 0.82 | DRD2 (0.40) | ADORA2AADORA1 | |
| SCHEMBL1713611 | 0.82 | DRD2 (0.40) | ADORA2AADORA1 | |
| SCHEMBL12381189 | 0.81 | CA1 (0.40) | CA1CA2CA9KMT2A | |
| SCHEMBL28142221 | 0.80 | DRD2 (0.39) | ADORA2AADORA1 | |
| SCHEMBL25353653 | 0.79 | ALPL (0.36) | ALPLCA1CA2 | |
| SCHEMBL4370623 | 0.79 | EPAS1 (0.38) | ADORA2AADORA1ALPLPDE4APDE4C | |
| SCHEMBL14985330 | 0.79 | HSD11B1 (0.38) | ADORA2AADORA1CA1CA2CA9 | |
| SCHEMBL30387806 | 0.79 | HSD11B1 (0.38) | ADORA2AADORA1CA1CA2CA9 | |
| SCHEMBL29458425 | 0.79 | SLC6A9 (0.44) | PTPN1ACLYADORA2AADORA1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180083203-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NES, CACNA2D4, PGLS | PTPN1 2347/4885ACLY 2643/4885ADORA2A 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.